Burst Expert Illustrations and Commentaries™: Visualizing Gene Therapy Approaches in Hemophilia A
September 13, 2021
September 13, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by educational grants from Spark Therapeutics.
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit(s)™
- Nurses — 0.25 Contact Hours
All other health care professionals completing this course will be issued a statement of participation.
This educational activity is directed toward hematologists, pediatricians, and primary care clinicians, medical geneticists, nurses, and other healthcare professionals who care for patients with hemophilia.
This Burst Expert Illustrations and Commentaries™ is a video-based program in which an expert discusses the etiology and emerging treatment of hemophilia A. In this activity, the faculty focuses on the pathophysiology of hemophilia A relevant to the use of gene therapy, which is currently under investigation. This discussion is enriched with the use of video animation to illustrate the mechanism of disease.
Upon completion of this activity, participants should be better able to:
- Assess the severity of hemophilia A according to clinical presentation and results of factor assays
- Analyze the potential impact of emerging therapies on the management of hemophilia A
Steven W. Pipe, MD
Professor of Pediatrics and Pathology, Coagulation
Medical Director, Pediatric Hemophilia and Coagulation Disorders Program
Director, Special Coagulation Laboratory
University of Michigan
Ann Arbor, MI
Physician Accreditation Statement
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.25 Contact Hours.
Disclosures of Conflicts of Interest
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Steven W. Pipe, MD
- Grant/Research Support: Siemens
- Consultant: ApcinteX, ASC Therapeutics, Bayer, BioMarin, Catalyst Biosciences, CSL Behring, HEMA Biologics, Freeline, Novo Nordisk, Pfizer, Roche/Genentech, Sangamo Theraputics, Sanofi, Takeda Oncology, Spark Therapeutics, uniQure
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.